Amgen Inc.
Methods for modulating mannose content of recombinant proteins

Last updated:

Abstract:

The present invention relates to methods of modulating (e.g., reducing) the mannose content, particularly high-mannose content of recombinant glycoproteins.

Status:
Grant
Type:

Utility

Filling date:

10 May 2016

Issue date:

10 Nov 2020